About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related ...
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
A new KFF health tracking survey found that one in eight U.S. adults have taken Ozempic or a similar GLP-1 drug at some point ...
KFF poll results suggest about 12 percent of adults in the U.S. have tried a GLP-1 drug like Ozempic to manage chronic health ...
A KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many ...
I’M MINDY BASARA IN TODAY’S MEDICAL ALERT, WEIGHT LOSS AND DIABETES DRUGS LIKE OZEMPIC WEGOVY AND ZYBAN ARE ALL THE RAGE RIGHT NOW. AND TO HELP BETTER UNDERSTAND WHAT’S HAPPENING WITH THESE ...
The US Food and Drug Administration has reported shortages of the GLP-1 medications Ozempic, Wegovy and Mounjaro at various dosages over the past year as drugmakers have raced to keep up with ...
(The Hill) — A new poll from the health policy nonprofit KFF found that one in eight adults say they’ve taken a GLP-1 agonist, the obesity and diabetes medications that include Ozempic ...
(CNN) — About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million ...